In Re Pharmaceutical Industry Average Wholesale Price Litigation
District Court, D. Massachusetts
1Opinion of the Court
MEMORANDUM AND ORDER
SARIS, District Judge.
INTRODUCTION
The United States brings this action under the False Claims Act, 31 U.S.C. § 3729 et seq., seeking to recover losses to the Medicare and Medicaid programs caused by allegedly fraudulent average wholesale prices for generic drugs reported by defendants Dey, Inc., Dey L.P., Inc., and Dey L.P. (collectively “Dey”).
Relator Ven-A-Care filed its qui tarn complaint against Dey in the Southern District of Florida on August 13, 1997. Nine years later, after seeking numerous sixty day extensions from the court, the government elected to intervene.…
2Cases cited31 opinions
- Rockwell International Corp. v. United StatesSupreme Court of the United States · 2007
- Henderson v. United StatesSupreme Court of the United States · 1996
- Badaracco v. CommissionerSupreme Court of the United States · 1984
- United States v. BornsteinSupreme Court of the United States · 1976
- LaChapelle v. Berkshire Life InsuranceCourt of Appeals for the First Circuit · 1998
26 more not listed; retrieve them via the Exa API.
3Cited by12 opinions
- Hayes v. Department of EducationDistrict Court, S.D. New York · 2014
- Miller v. HolzmannDistrict Court, District of Columbia · 2008
- United States v. Actavis Mid Atlantic LLCDistrict Court, D. Massachusetts · 2009
- United States Ex Rel. Ramadoss v. Caremark Inc.District Court, W.D. Texas · 2008
- United States ex rel. Estate of Gadbois v. Pharmerica Corp.District Court, D. Rhode Island · 2017
7 more not listed; retrieve them via the Exa API.